Maxim initiated coverage of Silexion Therapeutics (SLXN) with a Buy rating and $1 price target
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter